AMLX Kronos AI forecast
A 30-trading-day price forecast for Amylyx Pharmaceuticals Inc. (AMLX) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts Amylyx Pharmaceuticals Inc. at $26.64 on 2026-12-08, −5.9% from the last close of $28.30 on 2026-10-27. Eight out of ten sampled paths end between $20.44 and $28.86, and 3 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of AMLX
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $28.11 | $27.00 | $29.47 |
| 2026-11-10 | $28.80 | $26.51 | $30.31 |
| 2026-11-17 | $29.07 | $25.58 | $30.99 |
| 2026-11-24 | $27.81 | $24.74 | $32.01 |
| 2026-12-01 | $26.72 | $24.82 | $31.83 |
| 2026-12-08 | $26.64 | $20.44 | $28.86 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for AMLX?
- Kronos AI's median forecast for AMLX is $26.64 in 30 trading days, −5.9% from the last close, with a 10–90% range of $20.44 to $28.86.
- Is the AMLX Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- LLY — Eli Lilly and Company
- JNJ — Johnson & Johnson
- ABBV — AbbVie Inc.
- MRK — Merck & Company Inc.
- NVS — Novartis AG
- AZN — AstraZeneca PLC